Skip to main content

Major Depressive Disorder Excellence Forum

Major Depressive Disorder
Excellence Forum

Charles Raison, MD
Conference Coverage
09/18/2025
Charles L. Raison, MD
In this interview, Charles Raison, MD, Psych Congress Steering Committee Member, shares some of the key insights from his session presented at the 2025 Psych Congress: “The Role of Inflammation in Depression: Bridging Science and Clinical...
In this interview, Charles Raison, MD, Psych Congress Steering Committee Member, shares some of the key insights from his session presented at the 2025 Psych Congress: “The Role of Inflammation in Depression: Bridging Science and Clinical...
In this interview, Charles...
09/18/2025
Psych Congress Network
Headshot of Snoben Kuruvila
Videos
04/24/2025
Snoben Kuruvila, MPAS, PA-C
Following his insightful session at Psych Congress 2024, Snoben Kuruvila, MPAS, PA-C, sat down with Psych Congress Network to discuss emerging developments in major depressive disorder (MDD) treatment.
Following his insightful session at Psych Congress 2024, Snoben Kuruvila, MPAS, PA-C, sat down with Psych Congress Network to discuss emerging developments in major depressive disorder (MDD) treatment.
Following his insightful session...
04/24/2025
Psych Congress Network
Brittany Albright
Q&As
03/11/2025
Brittany B. Albright, MD, MPH
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and...
03/11/2025
Psych Congress Network
Dr Brittany Albright
Q&As
03/04/2025
Brittany B. Albright, MD, MPH
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress...
03/04/2025
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
Conference Coverage
11/12/2024
Jolynn Tumolo; Brionna Mendoza
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term...
11/12/2024
Psychiatry & Behavioral Health
Sandhya Prashad, MD
Q&As
05/30/2024

Featuring Sandhya Prashad, MD

Featuring Sandhya Prashad, MD
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses...
05/30/2024
Psych Congress Network
Jennifer S. De La Rosa, PhD
Q&As
03/22/2024

Featuring Jennifer S. De La Rosa, PhD

Featuring Jennifer S. De La Rosa, PhD...
Jennifer S. De La Rosa, PhD, discusses findings from a groundbreaking study on comorbid depression and/or anxiety and chronic pain.
Jennifer S. De La Rosa, PhD, discusses findings from a groundbreaking study on comorbid depression and/or anxiety and chronic pain.
Jennifer S. De La Rosa, PhD,...
03/22/2024
Psych Congress Network
Rakesh Jain, MD, MPH.
Videos
02/06/2024
Rakesh Jain, MD, MPH, RD
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains...
02/06/2024
Psych Congress Network
Rakesh Jain at Psych Congress Regionals
News
01/04/2024
Meagan Thistle
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered...
01/04/2024
Psych Congress Network
Dr Vlad Maletic
Videos
11/27/2023
Vladimir Maletic, MD
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores...
11/27/2023
Psychiatry & Behavioral Health